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Abstract (222 words) 
 
Background: Previous clinical trials have suggested that repetitive transcranial magnetic 
stimulation (rTMS) has a significant antidepressant effect in patients with treatment resistant 
depression (TRD). However, results remain heterogeneous with many patients without 
effective response. 
Objective: The aim of this SPECT study was to determine before treatment the predictive 
value of the connectivity of the stimulated area on further rTMS response in patients with 
TRD. 
Methods: Fifty-eight TRD patients performed a brain perfusion SPECT before high frequency 
rTMS of the left dorsolateral prefrontal cortex (DLPFC). A voxel based-analysis was 
achieved to compare connectivity of the left DLPFC in responders and non-responders using 
inter-regional correlations (p<0.005, corrected for cluster volume). A multiple logistic 
regression model was thereafter used with the goal of establishing a predictive score. 
Results: Before rTMS, responders exhibited increased SPECT connectivity between the left 
DLPFC and the right cerebellum in comparison to non-responders, independently of age, 
gender, severity of depression, and severity of treatment resistance. The area under the curve 
for the combination of these two SPECT clusters to predict rTMS response was 0.756 
(p<0.005).  
Conclusions: SPECT connectivity of the left DLPFC predicts rTMS response before 
treatment. 
 
Key words: Connectivity; SPECT; repetitive transcranial magnetic stimulation; treatment 
resistant depression; predictive value. 
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Highlights: 
• SPECT connectivity predicts rTMS response before treatment in TRD patients 
• This predictive value is independent of clinical known predictive factors 
• Increased SPECT connectivity is observed before rTMS in responders patients  
• This increased SPECT connectivity involves the left DLPFC and the right cerebellum 
• A model of predictive score involving these 2 clusters and their interaction is proposed 
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1. Introduction 
 
Approximately two-thirds of patients receiving initial antidepressant therapy do not 
achieve remission, and 20% have persistent resistance to conventional pharmacological 
treatments [1]. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive and 
well-tolerated method that may be an effective alternative therapeutic approach. Although 
previous clinical trials have suggested that rTMS has a significant antidepressant effect, 
results remain heterogeneous with many patients showing no response [2]. Regarding the 
medical cost of rTMS, which is time-consuming for both the physician and the patient, the 
identification of biomarkers of predictive response to rTMS seems necessary to optimize its 
effectiveness [3] .  
Using 99mTc-Ethyl-Cysteinate-Dimer (ECD) single photon emission computed 
tomography (SPECT), we previously reported that patients with Treatment-Resistant 
Depression (TRD) showed significant frontal and temporal hypoperfusion, with a left-side 
predominance [4,5]. Moreover, prior to treatment, non-responder patients showed greater 
hypoperfusion in the left medial and bilateral superior frontal cortices, in the left 
uncus/parahippocampal cortex, and in the right thalamus after rTMS of the dorso-lateral 
prefrontal cortex (DLPFC). These results suggest potential predictive value of 99mTc-ECD 
SPECT imaging involving remote regions from the stimulated area [4–6].  
On the other hand, the study of connectivity in SPECT is gaining interest in depression 
and neurologic disorders [5,7–10]. Seed correlations or interregional correlation analysis 
(IRCA) is one of the main approaches proposed to study SPECT connectivity [10,11]. This 
approach involves picking a reference location and quantifying the correlation with perfusion 
for every other brain area, as previously described [5,8]. SPECT connectivity has been shown 
to be disturbed in TRD patients, who show higher connectivity between left frontal and left 
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cerebellar regions in comparison to healthy subjects [5]. Indeed, in addition to its role in 
motor coordination, the cerebellum may play an important role in cognitive processing and 
emotional control by modulating limbic regions [12]. Interestingly, also by using SPECT 
connectivity, we have recently reported that the clinical effects of rTMS were related to 
changes in connectivity between the stimulated area and remote medial temporal limbic areas 
[8], explaining perfusion changes within the left perirhinal cortex found after treatment[6]. 
In the current study, we hypothesize that differences in SPECT connectivity of the left 
DLPFC before rTMS may be related to later clinical response in patients with TRD. 
 
2. Materials and Methods 
 
2.1. Subjects 
This retrospective study, conducted in a public psychiatric university hospital, 
involved 58 right-handed TRD patients, treated with high-frequency (HF) rTMS, as described 
previously [8]. All participants met DSM-IV TR criteria for major depressive disorder 
(unipolar or bipolar depression) without psychotic features, and gave informed consent. TRD 
was defined as a non-response to at least two different classes of antidepressant medications 
for the current episode at the time of enrolment. All patients had maintained stable doses of 
antidepressant and/or mood stabilizer medications for at least 2 weeks before treatment and 
until completing the course of rTMS. Finally, a group of 55 healthy subjects was extracted 
from a local normal 99mTc-ECD SPECT database constituting a control population approved 
by our local ethics committee (Clinical Trials Ref: NCT00484523), with similar age and 
gender as those of the patients group (p>0.15, 49.8 ±16.6 years old, 32 women), to compare 
results of connectivity analysis with patients. 
2.2 Data collection 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
The following data were recorded: demographic characteristics: gender and age; clinical 
characteristics: duration of illness, episode duration, depression severity using the 21-item 
Beck Depression Inventory (BDI-II) [13], and anxiety severity using the State Trait Anxiety 
Inventory (STAI-YA) [14]. The overall level of depression varies from minimal (score of 10) 
to severe (score > 29) depression. All patients were assessed twice with the BDI-II and STAI-
YA: before rTMS, and after 20 rTMS sessions. RTMS response was defined as at least 50% 
reduction in the baseline BDI-II score. Level of treatment-resistant severity was assessed with 
the Maudsley Staging Method (MSM) which is a point-based staging method that measures 
level of treatment-resistant severity of the index episode by incorporating 3 factors: treatment, 
severity of illness, and duration of episode [15]. The overall level of treatment resistance 
varies from minimal (score of 3) to severe (score of 15) resistance. 
 
2.3. RTMS treatment 
Magnetic stimulation was performed using a Medtronic MagPro X100 stimulator and 
a figure eight-shaped water-cooled coil (Medtronic Inc., Minnesota). Twenty sessions of 
rTMS were delivered daily but not including weekends, to the left DLPFC, situated 6 cm 
anterior to the motor “hotspot” for the contralateral hand muscles, with a frequency of 10Hz 
with a 25-second inter-train interval (2,000 pulses/day) at 120% of the resting motor 
threshold.  
 
2.4. SPECT protocol 
Brain perfusion SPECT was performed after injection of 740 MBq of 99mTc-ECD in 
all patients and healthy subjects, with the same camera and under the same conditions, during 
the week before rTMS in patients as previously reported [8].  
A voxel-by-voxel group study design was employed using SPM8 (Wellcome Department of 
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Cognitive Neurology, University College, London), running on Matlab (MathworksInc, 
Sherborn, MA), with normalization by proportional scaling. Based on the hypothesis that 
baseline connectivity of the stimulated area could explain further clinical response to the 
rTMS, we then studied SPECT connectivity of the left DLPFC. For this purpose, normalized 
perfusion values of the left BA46 volume-of-interest of PickAtlas® (ANSIR Laboratory, 
Department of Radiologic Sciences WFU School of Medicine, USA) used for the analysis of 
the left DLPFC and illustrated in Figure 1A, were individually extracted using Marsbar® 
(Marseille, France) software. Then a full factorial model of analysis was used with normalized 
perfusion of the left BA46 values as an interaction covariate to study inter-regional 
correlation, between responders and non-responders, with age, gender, depression severity 
(BDI) and therapeutic resistance (MSM) scores as covariates. The SPM (T) maps were 
obtained at a height threshold of p<0.005 for the voxel, with clusters including at least 102 
voxels (the expected threshold provided by SPM after simulation) to correct for volume, to 
avoid type II errors as recommended [16]. The normalized values of significant clusters from 
the full-factorial analysis were finally extracted using Marsbar® (Marseille, France) software, 
and used to calculate correlation coefficients with left DLPFC normalized values in 
responders, non-responders and healthy subjects. MNI coordinates were used to identify brain 
structures. 
 
2.5. Statistical analysis 
Quantitative variables are expressed as means ± standard deviations, and categorical variables 
as percentages. For patient’s characteristics, t-tests were done for mean comparisons for 
quantitative variables while Chi-2 tests were done for categorical variables. Statistical 
parameters for SPM comparison between responders and non-responders at baseline are 
detailed above. Spearman coefficients were used to calculate correlations between normalized 
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values of significant clusters from the full-factorial analysis with clinical scores and left 
DLPFC normalized values in responders, non-responders and healthy subjects. Then, multiple 
logistic regression models including the normalized values of left DLPFC and of significant 
clusters from the SPM analysis, and their interaction, were used with the goal of establishing a 
predictive score to classify patients in the responder vs non-responder groups. For this 
purpose, we split the data into two samples: a training sample including 2/3 of the data and a 
test sample including the remaining 1/3. Multiple logistic regression was performed to predict 
response to treatment using the training dataset. Predictive scores were then calculated and an 
area under the receiver operation characteristics curve (AUC under ROC) was derived to 
evaluate the discriminative ability of this score between responders and non-responders. A 
binormal smoothing was performed for building ROC curves. The AUC ranges from 0.5 to 
0.99 with higher values signifying higher model discrimination. In order to guarantee the 
robustness of our findings, the predictive score was applied on the test sample and we 
compared the AUC on the training and the testing datasets. Three different cutoff points were 
calculated by selecting the point on the ROC curve that maximized: (1) both sensitivity (Se) 
and specificity (Sp); (2) Se; and (3) Sp. The significance level p value for all statistical 
analyses was set at 0.05. 
 
3. Results 
3.1. Patient characteristics before rTMS 
Before rTMS, the 58 patients (53.8 years ±14.0; 37 women) presented depression and 
anxiety with initial high severity (BDI-II=25.9±9.5, STAI-YA=63.2±10.9) and moderate 
treatment resistance (MSM=8.7±2.1). The episode duration was of 17.3 months ±8.1. Forty-
four patients had unipolar depression, and 14 bipolar depression. After rTMS, 27 were 
responders (46.6%). Baseline characteristics of responder and non-responder groups are 
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presented in Table 1. There were no statistically significant differences in demographic and 
clinical characteristics (p>0.10), apart from a greater degree of treatment resistance (p=0.033) 
and a tendency for worse depression severity (p=0.079) in non-responders. 
 
3.2 SPECT connectivity findings 
Before rTMS, responders exhibited increased SPECT connectivity between the left DLPFC 
and the right cerebellum (p<0.005, k=102) compared to non-responders, even after controlling 
for age, gender, depression severity and treatment resistance (Figure 1B). No other difference 
in SPECT connectivity was found between responders and non-responders.  
Correlation coefficients between left DLPFC and right cerebellum values were 0.559 in 
responders (p<0.01) whereas -0.123 (p=0.51) for non-responders, and -0.086 (p=0.53) for 
healthy subjects.  
The two SPECT clusters (left DLPFC stimulated area and right cerebellum) and their 
interaction were selected for the multiple logistic regression models to predict the response to 
rTMS. From this analysis on the training sample, the following equation was obtained: 
predictive score = exp(292.622 + 0.063 × inter – 3.397 × right cerebellum cluster – 5.460 × 
left DLPFC cluster) / (1+exp(292.622 + 0.063 × inter - 3.397 × right cerebellum cluster -
5.461 × left DLPFC cluster). The AUC for the combination of SPECT clusters was 0.756 
(p<0.005) (Fig. 2). The robustness of the predictive score was confirmed with similar AUC 
(0.808) for the test sample.  
The cut-off points of the combination of SPECT clusters that maximized (1) both Se and Sp 
was > 0.36 (Se=90%, Sp=60%); (2) Se was > 0.16 (Se=100%, Sp=30%); and (3) Sp was 
>0.30 (Se=30%, Sp=100%).  
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4. Discussion 
 
This perfusion SPECT study aimed to characterize left DLPFC connectivity in TRD patients 
who underwent rTMS to define neuroimaging biomarkers that discriminate non-responders 
from responders. Our findings, obtained in a large sample using SPECT, support the existence 
of increased connectivity between the stimulated left DLPFC area and the right cerebellum in 
responders before rTMS, independently of common clinical predictive factors such as age, 
gender, depression severity or therapeutic resistance. 
Our previous SPECT study showed higher connectivity in TRD patients in comparison to 
healthy subjects [5]. We now show that increased connectivity is particularly associated with 
subsequent therapeutic response to left DLPFC rTMS in TRD. It could thus mean that 
responders are those who exhibit especially high SPECT connectivity between the DLPFC 
and certain remote areas of the brain [6]. In line with this, increased connectivity between the 
DLPFC stimulated area and the cerebellum has already been reported in resting-state 
functional MRI studies in patients with depression [17,18]. Interestingly in a recent FDG-PET 
study, higher cerebellar metabolism has been found to be indicative of beneficial response to 
high frequency-rTMS treatment [17]. These results suggest the novel role of the cerebellum in 
the pathophysiology of depression, particularly in the clinical outcome  [17].   
Changes in connectivity of the stimulated area are also predictive of the response after rTMS 
for TRD according to fMRI studies. Indeed, by targeting the dorso-medial prefontal cortex 
(DMPFC), responders to rTMS also showed increased resting state connectivity, but mainly 
between the DMPFC and the ventromedial prefrontal cortex [18,19]. However, this contrasts 
with other studies that have shown that changes in functional connectivity to remote areas are 
rather predictive of better response to treatment of rTMS of left DLPFC, such as subgenual 
cortex [9,20] or cingular cortex [21]. 
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The present study brings a predictive model for assessing rTMS response in TRD including 
SPECT normalized values of the left DLPFC stimulated area and the right cerebellum with 
good performances (AUC of 0.808 in the test sub-group). Thus, several cut-offs of normalized 
perfusion values for left DLPFC and the right cerebellum could be proposed (Figure 2). One 
option would be to offer rTMS only to those patients in whom the model would predict a 
good response with high specificity. On the other hand, by choosing normalized perfusion 
values with good sensitivity for predicting treatment response, a high number of TRD patients 
could be treated. 
Otherwise, our study reports that patients with higher degree of treatment resistant and 
depression severity presented a statistical trend for lower response to rTMS. Even if these 
predictive factors did not influence our SPECT results, this confirms previous research which 
has identified the main predictive clinical characteristics as longer duration of the episode, 
treatment refractoriness or age [17,22]. 
Several limitations have to be carefully considered. Interpretation of these data should be 
performed in the context of the study design, namely, an observational study in which 
treatment was offered to all participants in an open label fashion. Second, our sample included 
patients with unipolar and bipolar depression; however, previous studies have reported that 
patterns of SPECT perfusion were similar in these two groups of patients [5,9,17-21,23]. 
Third, as in previous studies, our participants were treated with rTMS as add-on therapy. 
To conclude, SPECT connectivity of the to-be-stimulated left DLPFC area before rTMS has 
an independent predictive value in terms of treatment response, even after taking into account 
clinical known prognostic factors such as age, gender, depression severity or therapeutic 
resistance. Patients with higher SPECT connectivity between the stimulated area and the 
cerebellum can be expected to have a better response to rTMS. Therefore, it seems that 
connectivity of the target before rTMS is linked mechanistically to the successful response. 
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Future studies should be aimed exploring other target areas for rTMS in non-responders. 
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Figure 1. Anatomical localization of Region Of Interest (ROI) of left Dorso-Lateral 
Prefrontal Cortex (DLPFC) (in A) and of area of increased left DLPFC connectivity in 
responders in comparison to non-responders (in B) projected onto sections of a normal MRI 
set spatially normalized and smoothed into the standard SPM8 template (p<0.005, 
uncorrected, k>102). Before rTMS, responders exhibited increased SPECT connectivity 
between left DLPFC and right cerebellum (in B) compared to non-responders. 
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Figure 2. Receiver-operating characteristic (ROC) curve for prediction of response to rTMS 
according to the combination of SPECT connectivity clusters on a training sample including 
2/3 of the data.  
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Table 1. Baseline characteristics of responders and non-responders (n=58) 
SD: standart deviation; BDI-II : Beck Depression Inventory 21 items;  STAI-YA: State 
Anxiety Inventory-State; MSM : Maudsley Staging Method 
 
 
 
 
 Responders (n=27) Non-responders (n=31)  
 Mean (SD) Mean (SD) p-value 
 
Demographic characteristics 
  
   Gender (male), n (%) 11 (40.7%) 10 (32.3%) 0.346 
   Age 54.4 (12.0) 53.6 (15.4) 0.829 
 
Clinical characteristics 
  
   Depression    
     Unipolar, n (%) 18 (66.7%) 26 (83.9%) 0.111 
     Bipolar, n (%) 9 (33.3%) 5 (16.1%) 0.111 
Illness duration (years) 15.3 (10.9) 18.0 (12.4) 0.397 
Episode duration (months)    
     < 24 months, n (%) 12 (44.4%) 13 (41.9%) 0.529 
     > 24 months n (%) 15 (55.6%) 18 (58.1%) 0.529 
Failed antidepressant trials 
current episode 3.5 (2.0) 4.3 (1.8) 0.143 
BDI-II score 23.6 (10.0) 28.0 (8.6) 0.079 
STAI score 64.0 (9.5) 65.2 (8.9) 0.622 
MSM score 8.1 (2.0) 9.2 (2.0) 0.033* 
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Table 1. Baseline characteristics of responders and non-responders (n=58) 
 
SD: standart deviation; BDI-II : Beck Depression Inventory 21 items;  STAI : State Anxiety 
Inventory-State; MSM : Maudsley Staging Method 
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M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
Figure 1. Anatomical localization of Region Of Interest (ROI) of left Dorso-Lateral 
Prefrontal Cortex (DLPFC) (in A) and of area of increased left DLPFC connectivity in 
responders in comparison to non-responders (in B) projected onto sections of a normal MRI 
set spatially normalized and smoothed into the standard SPM8 template (p<0.005, 
uncorrected, k>102). Before rTMS, responders exhibited increased SPECT connectivity 
between left DLPFC and right cerebellum (in B) compared to non-responders. 
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Figure 2. Receiver-operating characteristic (ROC) curve for prediction of response to rTMS 
according to the combination of SPECT connectivity clusters on training and test samples 
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Highlights: 
• Pretherapeutic SPECT connectivity of the DLPFC predicts antidepressant effect of TMS. 
• Responders show increased connectivity between the targeted area and the cerebellum. 
• A mathematical model of predictive score involving these two regions is proposed.  
